Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

282 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2.
Glasgow A, Glasgow J, Limonta D, Solomon P, Lui I, Zhang Y, Nix MA, Rettko NJ, Lim SA, Zha S, Yamin R, Kao K, Rosenberg OS, Ravetch JV, Wiita AP, Leung KK, Zhou XX, Hobman TC, Kortemme T, Wells JA. Glasgow A, et al. Among authors: ravetch jv. bioRxiv [Preprint]. 2020 Aug 4:2020.07.31.231746. doi: 10.1101/2020.07.31.231746. bioRxiv. 2020. PMID: 32766586 Free PMC article. Updated. Preprint.
Antibody potency, effector function and combinations in protection from SARS-CoV-2 infection in vivo.
Schäfer A, Muecksch F, Lorenzi JCC, Leist SR, Cipolla M, Bournazos S, Schmidt F, Gazumyan A, Baric RS, Robbiani DF, Hatziioannou T, Ravetch JV, Bieniasz PD, Nussenzweig MC, Sheahan TP. Schäfer A, et al. Among authors: ravetch jv. bioRxiv [Preprint]. 2020 Sep 15:2020.09.15.298067. doi: 10.1101/2020.09.15.298067. bioRxiv. 2020. PMID: 32995782 Free PMC article. Updated. Preprint.
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2.
Glasgow A, Glasgow J, Limonta D, Solomon P, Lui I, Zhang Y, Nix MA, Rettko NJ, Zha S, Yamin R, Kao K, Rosenberg OS, Ravetch JV, Wiita AP, Leung KK, Lim SA, Zhou XX, Hobman TC, Kortemme T, Wells JA. Glasgow A, et al. Among authors: ravetch jv. Proc Natl Acad Sci U S A. 2020 Nov 10;117(45):28046-28055. doi: 10.1073/pnas.2016093117. Epub 2020 Oct 22. Proc Natl Acad Sci U S A. 2020. PMID: 33093202 Free PMC article.
Fc-engineered antibody therapeutics with improved efficacy against COVID-19.
Yamin R, Jones AT, Hoffmann HH, Kao KS, Francis RL, Sheahan TP, Baric RS, Rice CM, Ravetch JV, Bournazos S. Yamin R, et al. Among authors: ravetch jv. Res Sq [Preprint]. 2021 May 27:rs.3.rs-555612. doi: 10.21203/rs.3.rs-555612/v1. Res Sq. 2021. PMID: 34075373 Free PMC article. Updated. Preprint.
Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy.
Yamin R, Jones AT, Hoffmann HH, Schäfer A, Kao KS, Francis RL, Sheahan TP, Baric RS, Rice CM, Ravetch JV, Bournazos S. Yamin R, et al. Among authors: ravetch jv. Nature. 2021 Nov;599(7885):465-470. doi: 10.1038/s41586-021-04017-w. Epub 2021 Sep 21. Nature. 2021. PMID: 34547765 Free PMC article.
Synthetic nanobodies as tools to distinguish IgG Fc glycoforms.
Kao KS, Gupta A, Zong G, Li C, Kerschbaumer I, Borghi S, Achkar JM, Bournazos S, Wang LX, Ravetch JV. Kao KS, et al. Among authors: ravetch jv. Proc Natl Acad Sci U S A. 2022 Nov 29;119(48):e2212658119. doi: 10.1073/pnas.2212658119. Epub 2022 Nov 21. Proc Natl Acad Sci U S A. 2022. PMID: 36409896 Free PMC article.
282 results